Research Reveals Immune Cells Linked to Alzheimer's May Originate Outside the Brain
Researchers have uncovered a surprising origin for immune cells that contribute to Alzheimer's disease progression. The study found that these disease-associated immune cells may be activated in lymph nodes outside the brain before traveling into the central nervous system.
In mouse experiments, blocking this cellular migration pathway led to a dramatic reduction in neurodegeneration and preserved cognitive abilities. This finding is significant because it suggests that treatments targeting the immune system's peripheral activation—rather than attempting to intervene directly in the brain—could be a viable approach to slowing Alzheimer's progression.
The discovery points to lymph nodes as a potentially more accessible treatment target compared to the brain, which is protected by the blood-brain barrier and historically difficult to treat with systemic therapies.